AVXL | Anavex Life Sciences Corp
Category: Consumer goods
Quick infos Headquarters: New York City, New York, United States Trade prices Volume: Market Cap: 694.56M Prev closed: 20.99 Open: 19.91 High: 20.32 Low: 16.95 52 week low: 3.61 52 week high: 28.7 Dividends: No Dividends Next ER: May 10, 2022 After Market Closes
Earnings History Date EPS / Forecast Revenue / Forecast August 11, 2022 May 10, 2022 -0.14 / -0.1667- / -February 9, 2022 -0.14 / -0.155- / -November 24, 2021 -0.16 / -0.1461- / -August 12, 2021 -0.14 / -0.134- / -view more
Historical Data Date Price Open High Low Vol Change ER May 10, 2022 7.69 8.15 8.50
7.28
1.35M 1.32% May 9, 2022 7.59 8.05 8.39
7.38
1.48M -9.1% May 6, 2022 8.35 8.86 8.86
8.26
997.14K -7.53% May 5, 2022 9.03 9.56 9.71
8.77
816.32K -7.48% May 4, 2022 9.76 9.25 9.84
8.89
758.87K 5.40% May 3, 2022 9.26 9.09 9.33
9.00
535.24K 2.32% May 2, 2022 9.05 8.57 9.05
8.55
1.05M 5.36% Apr 29, 2022 8.59 8.90 9.29
8.58
719.72K -4.45% Apr 28, 2022 8.99 9.10 9.14
8.50
741.21K 0.78% Apr 27, 2022 8.92 9.07 9.37
8.88
633.75K -1.22% view more
NASDAQ - Nasdaq Stock Market
News
How Anavex Extended Its 5-Week Rally On Promising Results In Rett Syndrome investors.com Apr 27, 2022 4:10 pm
Anavex Life Sciences Corp. to Host Earnings Call finance.yahoo.com Apr 27, 2022 2:30 pm
Dow Jones Today Aims To Snap Sell-Off As Nasdaq Reverses; Chevron, Caterpillar Rebound; Yields Edge Up Ahead Of Powell Testimony investors.com Apr 27, 2022 10:02 am
Anavex Life Sciences' Alzheimer's Candidate Mechanism Of Action Explained In Medical Journal finance.yahoo.com Apr 27, 2022 9:51 am
Company News for Jun 15, 2021 finance.yahoo.com Apr 27, 2022 9:40 am Anavex Higher on Phase 2 Progress With Parkinson's Drug thestreet.com Apr 27, 2022 7:04 am Morgan Stanley projects about a third of biotechs will need financing in 2022 seekingalpha.com Mar 27, 2022 Anavex posts mid-stage biomarker data for lead candidate seekingalpha.com Mar 15, 2022 8:19 pm Anavex CEO addresses Rett syndrome drug data controversy in quarterly call seekingalpha.com Feb 10, 2022 10:17 pm
Anavex CEO Says 'Inaccurate Impression' Clouded Rett Drug's Promise investors.com Feb 1, 2022 6:28 pm
Anavex Life Sciences to Announce Fiscal 2021 First Quarter Financial Results and Business Outlook on Thursday, February 11, 2021 finance.yahoo.com Apr 27, 2022 7:00 am
Anavex Life Sciences Reports Fiscal 2021 Second Quarter Financial Results And Business Outlook finance.yahoo.com Apr 27, 2022 7:00 am
Anavex Life Sciences Announces Notice of Allowance for U.S. Patent Application ANAVEX®2-73 (blarcamesine) for the Treatment of Cardiac Dysfunctions finance.yahoo.com Apr 27, 2022 7:00 am
Anavex Life Sciences Announces ANAVEX®2-73 (Blarcamesine) Biomarker Correlated with Efficacy Endpoints in Placebo-Controlled U.S. Phase 2 Clinical Trial for the Treatment of Adult Patients with Rett Syndrome finance.yahoo.com Apr 27, 2022 7:00 am
Anavex Life Sciences Announces ANAVEX®2-73 (Blarcamesine) Significantly Prevented A (Abeta)-induced Cognitive Deficits with Confirmed Significant Biomarker-response in Animal Model of Alzheimers Disease finance.yahoo.com Apr 27, 2022 7:00 am
Anavex Life Sciences Announces Uplisting to the NASDAQ Global Select Market® finance.yahoo.com Apr 27, 2022 7:00 am
ANAVEX®2-73 (Blarcamesine) AVATAR Phase 3 Trial met Primary and Secondary Efficacy Endpoints for the Treatment of Adult Patients with Rett Syndrome finance.yahoo.com Apr 27, 2022 7:00 am
Anavex Life Sciences to Present at the 11th Annual SVB Leerink Global Healthcare Conference finance.yahoo.com Apr 27, 2022 7:00 am
Anavex Life Sciences Announces Presentation of Phase 2 Clinical Biomarker Data from ANAVEX®2-73-PDD-001 Parkinsons Disease Dementia Study at AD/PD 2022 International Conference finance.yahoo.com Apr 27, 2022 7:00 am
Anavex Life Sciences Invited to Present at the B. Riley Securities' 2022 Virtual Neuro & Ophthalmology Conference finance.yahoo.com Apr 26, 2022 7:00 am This company doesn't provide a dividend.
Talk about Anavex Life Sciences Corp below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Consensus BUY 100 HOLD 0 SELL 0
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.